People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The NDA is supported by data from a clinical trial that compared the absorption and efficacy of the nasal treatment with oral and IV bumetanide in 68 healthy adults.

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...

Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...

A spritz of the so-called “love hormone” might be the key to easing persistent feelings of loneliness. In a 2014 study, a ...

The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder.

There are few things more dispiriting than wearing a new pair of shoes on a bad weather day, then coming home and finding water stains or rings of road salt once they’ve dried. Although there ...

Exercise can lead to rhinitis (nasal inflammation) symptoms, such as sneezing, a runny nose, nasal congestion, or an itchy nose. Two common forms of rhinitis that can lead to a runny nose when ...